North America

Thu
02
May

Research begins to develop medical cannabis suppositories for patients suffering from IBD

Panaxia Pharmaceutical Industries Israel and the pharmaceutical company Rafa, announced the signing of a collaboration agreement with PlantEXT Ltd., an Israeli-Canadian medical cannabis company in a recent press release.

Thu
02
May

New funding for cannabis research offers MS patients hope for the future

When Jessica Turner was diagnosed with multiple sclerosis (MS) at age 31, she didn’t want to talk about it—and she didn’t want to take drugs.

“I wasn’t ready to accept that this was happening to me,” Turner tells The GrowthOp. She also didn’t want to accept experiencing the flu-like symptoms that so often accompany interferons, the oldest and most prescribed drug options for patients with relapsing-remitting MS.

Wed
01
May

Cannabis stocks can be a lucrative — but risky — bet

Cannabis stocks aren't just another market fad. They can be a solid long-term bet — as long as you're careful.

Wed
01
May

New study: CBD diminishes THC-related impairment

In a new study from the University College London (UCL), a team of researchers focused on the difference between consuming cannabis strains that have high levels of THC, and strains that have significant quantities of both THC and CBD.

The precise effects on the brain were monitored by an fMRI (functional magnetic resonance imaging), which measures changes in blood flow and neural activity.

Brain scans of the 17 participants showed that the high-THC strain impaired the functionality of the default mode network, especially in the posterior cingulate area.

Wed
01
May

How cannabis microdosing can be used for pain management

Medical cannabis is currently legal in 29 states. Of those, none provide insurance coverage for the substance. This leaves consumers in a difficult situation: choose to purchase cannabis at their own expense or choose a potentially more harmful or addictive pharmaceutical medication covered by insurance. The dilemma is not new, but consumers and entrepreneurs alike are creating inventive ways to deal with the problem.

Wed
01
May

Moosehead enters cannabis drink market with Sproutly joint venture

Moosehead Breweries Ltd., one of Canada’s largest brewers, is getting into the cannabis business.

The Saint John, N.B.-based brewer announced it plans to form a joint venture with Sproutly Canada Inc., a cannabis producer and extractor, to develop pot-infused beverages that will be released later this year in the Canadian market.

“With the anticipated legalization of edibles in Canada later this year, Moosehead has made the strategic decision to enter the cannabis beverage market,” said Andrew Oland, CEO of Moosehead, in a release. “As one of the oldest brands in Canada and a leader in the beer category, we believe we are uniquely positioned to be a leader in the cannabis beverage category.”

Wed
01
May

Treating complex post-traumatic stress disorder (C-PTSD) with medical cannabis

“I’ve got to treat my body if I’m ever going to recover from this illness,” Kimberly Callis, an independent researcher with Complex Post-Traumatic Stress Disorder, tells High Times. “Cannabis [is] a systemic medicine; complex PTSD is a systemic condition. The two really go hand-in-hand, especially with a target on the endocannabinoid system.”

Wed
01
May

Say hello to the marijuana industry's secret weapon

In case you haven't noticed, the cannabis industry is blossoming before our eyes. Having long been considered a taboo topic that legislators swept under the rug, marijuana is finding support in a growing number of countries around the world.

Wed
01
May

Cannabis & main: Legal cannabis delivery 'is about being treated equally and legitimately'

Civilized's podcast 'Cannabis & Main' is back with celebrated marijuana journalist Riccardo Baca returning to host the second season, writes Ricardo Baca. To kick things off, Ricardo chatted with Jordan Wellington - a public policy advisor for the cannabis law firm Vicente Sederberg and and former member of the Colorado Marijuana Enforcement Division.

Wed
01
May

Cannabis industry blooming with tech opportunities

Cannabis is now a big, legal business in much of the United States.

Since California legalized its medical use in 1996, the industry that grows, packages, markets, distributes and sells marijuana has grown into a $10 billion-a-year business that employs more than 210,000 people, according to the web site Leafly. Industry executives say these pot-centric companies range in size from less than 10 employees to several hundred, with a handful counting their headcount in the thousands. Revenue ranges from the low millions to an estimated $100 million or more. 

Pages

Subscribe to RSS - North America